Michael J. Fox’s 35-year Parkinson’s journey: 6 lessons worth sharing with patients
Industry Buzz
There’s no timeline, there’s no series of stages that you go through. [Parkinson’s] much more mysterious and enigmatic… There are not many people who have had Parkinson’s for 35 years.
—Michael J. Fox
When Michael J. Fox recently remarked that he’s lived with Parkinson’s disease for 35 years, he wasn’t merely making a biographical point.[]
He was, in part, delivering a message to clinicians, patients, and anyone watching: Long journeys with neurodegenerative disease are possible, and there’s much to learn from how he’s navigated each chapter of his life and career.
“There’s no timeline, there’s no series of stages that you go through—not in the same way that you would, say, with prostate cancer. [Parkinson’s] much more mysterious and enigmatic,” Fox recently told The Sunday Times. “There are not many people who have had Parkinson’s for 35 years."[]
For physicians treating patients newly diagnosed with Parkinson’s, Fox’s journey offers both cautionary lessons and hopeful possibilities.
How has Fox continued to act, create, and advocate while living with Parkinson’s? What strategies, mindset shifts, and supports have helped him stay engaged? And how can we, as clinicians, support our patients to live as fully as possible—not just longer, but with purpose?
Related: Data shows more people are getting Parkinson’s younger—but why?Outliving prognoses with flexibility and acceptance
When Fox was first diagnosed in 1991, few would have predicted he’d still be an active voice in Parkinson’s three decades later.[]
In 1998, when Fox shared his diagnosis publicly, his physician expected that he might remain functional for another 10 years.[] Yet Fox has continued to adapt, recalibrate, and push the boundaries of what “functional” means.
In a recent interview with PEOPLE ahead of his new memoir Future Boy, Fox described how he begins each day by listening to his body before deciding what to do.[] He also said he now “roll[s] around in a wheelchair a lot” and navigates new challenges physically.
Acting through it: The role of identity, purpose, and adaptation
One of Fox’s more remarkable feats has been to continue acting—not in spite of Parkinson’s, but with it.
Most recently, he took on a guest role in Shrinking, in which he plays someone with Parkinson’s.[] In doing so, he didn’t try to mask his symptoms completely—he embraced them as part of his performance.
This speaks to a critical idea: Rather than compartmentalizing “before disease” and “after disease,” Fox has woven his condition into his identity as a creator and advocate. His acting gives him purpose, structure, and continued social engagement.
For doctors, this underscores an often-neglected axis of care: role maintenance. Helping patients find ways to preserve or adapt the roles—professional, familial, and social—that give them meaning can be a powerful therapeutic tool, psychologically and physiologically.
Resilience, optimism, and emotional realism
Fox has never painted his life with Parkinson’s as a rosy journey. He has spoken candidly about pain, frustration, loss (eg, losing the ability to play guitar), and the mystery of the disease’s course.[][]
But he also balances that with a pragmatism and optimism grounded in gratitude. As he’s said, “Parkinson’s disease is the gift that keeps on taking. But it’s a gift.”[]
Related: Is Parkinson’s linked to a virus we thought was harmless?Normalize the long haul: Many patients newly diagnosed with Parkinson’s are terrified by the narratives they hear of decline, loss, and incapacity. Fox’s story offers a counternarrative: decades of living, adaptation, and advocacy. As clinicians, we can share stories of long-term survivors, while acknowledging selection bias, to help contextualize what’s possible.
Emphasize adaptive goal-setting: Fox didn’t cling to acting at all costs; he accepted changing demands. He listens to his body, adjusts, and isn’t afraid to say “no.” Encourage patients to set flexible, tiered goals—daily, weekly, and yearly—that account for variability.
Support role continuity: Ask what roles—professional, creative, and social—matter most. Then work with occupational therapy, rehabilitation, assistive devices, or even role redesign so that patients can stay engaged in meaningful pursuits, even if their disease evolves.
Co-treat the psychological and existential dimension of Parkinson’s: Fox’s sense of meaning, gratitude, and acceptance has been as important to him as any pill. Clinicians should anticipate and screen for existential distress, depression, and anxiety, and collaborate with counselors, spiritual care teams, or coaches.
Model prognostic humility and shared agency: Fox’s survival is anomalous and not fully explained. As doctors, we should present a patient’s prognosis with humility and avoid conveying that patients have “failed” if progression occurs. Instead, frame the fight as co-ownership: We do what we can, adapt, and reassess.
Leverage community, advocacy, and peer support: Fox’s activism and Parkinson’s foundation have built community. Though few patients have his platform, clinicians can still refer patients to peer groups, foundations (like the Michael J. Fox Foundation), and volunteer or advocacy roles that foster agency and connection.